Connect Biopharma Holdings (CNTB) Times Interest Earned (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Times Interest Earned of -$26.5 for Q1 2026, up 82.41% year-on-year from -$14.53 in Q1 2025, and up 77.64% on a QoQ basis from -$118.52 in Q4 2025.
Connect Biopharma Holdings (CNTB) Times Interest Earned (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Times Interest Earned for 3 consecutive years, with -$26.5 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned rose 82.41% year-over-year to -$26.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$89.51 (down 27.11% YoY) and the FY2025 annual result came in at -$0.85, down 156.28% from the prior year.
- Times Interest Earned rose to -$26.5 in Q1 2026 per CNTB's latest filing, from -$118.52 in the prior quarter.
- Over the last five years, Times Interest Earned for CNTB reached as high as $181.95 in Q2 2024 and fell as low as -$182.18 in Q3 2024.
- A 3-year average of -$81.23 and a median of -$126.33 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2025 — Times Interest Earned tumbled 107.64% — and 2026, when it surged 82.41%.
- Year by year, Times Interest Earned stood at -$128.25 in 2024, then gained by 7.59% to -$118.52 in 2025, then jumped by 77.64% to -$26.5 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$26.5, -$118.52, and -$166.76 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | -26.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.50 |
| Dec 31, 2025 | -118.52 |
| Sep 30, 2025 | -166.76 |
| Jun 30, 2025 | -13.90 |
| Mar 31, 2025 | -150.62 |
| Dec 31, 2024 | -128.25 |
| Sep 30, 2024 | -182.18 |
| Jun 30, 2024 | 181.95 |
| Mar 31, 2024 | -126.33 |